IZANA BIOSCIENCE LIMITED

W11 4UX (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£1,345,074

Dec 17 - Nov 19

Proof of Concept clinical trial for Izana Biosciences’ Namilumab in ankylosing spondylitis patients.

Innovate UK award to IZANA BIOSCIENCE LIMITED

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}